Design, Synthesis, Molecular Docking Studies, and Biological Evaluation of 1, 3, 4-oxadiazol-3(2H)-yl] Ethan-1-one Derivatives as Antimicrobial Agents †
Abstract
:Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Likhar, R.; Khan, T. Design, Synthesis, Molecular Docking Studies, and Biological Evaluation of 1, 3, 4-oxadiazol-3(2H)-yl] Ethan-1-one Derivatives as Antimicrobial Agents. Med. Sci. Forum 2022, 14, 143. https://doi.org/10.3390/ECMC2022-13247
Likhar R, Khan T. Design, Synthesis, Molecular Docking Studies, and Biological Evaluation of 1, 3, 4-oxadiazol-3(2H)-yl] Ethan-1-one Derivatives as Antimicrobial Agents. Medical Sciences Forum. 2022; 14(1):143. https://doi.org/10.3390/ECMC2022-13247
Chicago/Turabian StyleLikhar, Rupali, and Tabassum Khan. 2022. "Design, Synthesis, Molecular Docking Studies, and Biological Evaluation of 1, 3, 4-oxadiazol-3(2H)-yl] Ethan-1-one Derivatives as Antimicrobial Agents" Medical Sciences Forum 14, no. 1: 143. https://doi.org/10.3390/ECMC2022-13247